119 related articles for article (PubMed ID: 2664884)
1. The relationship between perphenazine plasma levels and clinical response in acute schizophrenia.
Omérov M; Wistedt B; Bolvig-Hansen L; Larsen NE
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):159-66. PubMed ID: 2664884
[TBL] [Abstract][Full Text] [Related]
2. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study.
Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S
J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413
[TBL] [Abstract][Full Text] [Related]
4. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
[TBL] [Abstract][Full Text] [Related]
5. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice.
Hansen LB; Larsen NE
Psychopharmacology (Berl); 1985; 87(1):16-9. PubMed ID: 3933033
[TBL] [Abstract][Full Text] [Related]
7. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
[TBL] [Abstract][Full Text] [Related]
8. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics.
Collins AD; Dundas J
Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295
[No Abstract] [Full Text] [Related]
9. Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.
Hansen LB; Larsen NE; Vestergård P
Psychopharmacology (Berl); 1981; 74(4):306-9. PubMed ID: 6794071
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
Kane JM; Meltzer HY; Carson WH; McQuade RD; Marcus RN; Sanchez R;
J Clin Psychiatry; 2007 Feb; 68(2):213-23. PubMed ID: 17335319
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Eufe R; Wegener G
Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
[No Abstract] [Full Text] [Related]
12. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.
Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS
Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572
[TBL] [Abstract][Full Text] [Related]
13. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of bromperidol and perphenazine.
Woggon B; Angst J
Int Pharmacopsychiatry; 1978; 13(3):165-76. PubMed ID: 355182
[TBL] [Abstract][Full Text] [Related]
15. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships of perphenazine in the treatment of acute psychoses.
Hansen LB; Larsen NE; Gulmann N
Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
[TBL] [Abstract][Full Text] [Related]
17. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.
Talvik M; Nordström AL; Larsen NE; Jucaite A; Cervenka S; Halldin C; Farde L
Psychopharmacology (Berl); 2004 Sep; 175(2):148-53. PubMed ID: 15007534
[TBL] [Abstract][Full Text] [Related]
18. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
Knudsen P; Hansen LB; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
[TBL] [Abstract][Full Text] [Related]
19. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
[TBL] [Abstract][Full Text] [Related]
20. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
Prusoff BA; Williams DH; Weissman MM; Astrachan BM
Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
